Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 January 2026, 13:30 (CET) to 30 January 2026, 15:30 (CET)

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Exelon, rivastigmine, Date of authorisation: 11/05/1998, Revision: 51, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness